Evening with AxoGen CEO Karen Zaderej

Join us as we extend the conversation from November’s IPO panel to a discussion of some nontraditional paths to market. Karen Zaderej, CEO of AxoGen, Inc., will share insights from the process of becoming and being a public company through a reverse merger and the pursuit of the BLA (Biologics License Application) path to market in a medtech world. Additionally, she’ll discuss her passion around maintaining an entrepreneurial culture in a growing company.

Thursday February 19, 2015
6:00 PM – 8:00 PM
Sofitel San Francisco Bay